M. Scot Roberts - 31 Jul 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Scientific Officer
Signature
/s/ Greg Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
31 Jul 2025
Transactions value $
$2,656
Form type
4
Filing time
04 Aug 2025, 16:05:21 UTC
Previous filing
03 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roberts M Scot Chief Scientific Officer C/O ALTIMMUNE, INC.,, 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG /s/ Greg Weaver, as Attorney-in-Fact 04 Aug 2025 0001705905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $2.66K +846 +1.16% $3.14 74.1K 31 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2025.